|
Apr 24
|
Viking Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
|
|
Apr 24
|
3 Biotech Stocks With Skyrocketing Potential: April 2024
|
|
Apr 24
|
3 Red-Hot Biotech Rockets Blasting Off in 2024
|
|
Apr 24
|
Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon.
|
|
Apr 23
|
Brian Big Idea On Technical Analysis
|
|
Apr 23
|
Better Buy: Pfizer vs. Viking Therapeutics
|
|
Apr 23
|
3 Stocks With the Potential to Surpass Analyst Expectations for 2024
|
|
Apr 19
|
Viking Therapeutics, Inc. (VKTX) Suffers a Larger Drop Than the General Market: Key Insights
|
|
Apr 19
|
Viking (VKTX) to Report Q1 Earnings: What's in the Cards?
|
|
Apr 17
|
Viking Therapeutics to Report Financial Results for First Quarter 2024 on April 24, 2024
|
|
Apr 16
|
These 3 Biotech Stocks Are Up 269% in 2024. Is There More to Come?
|
|
Apr 13
|
3 Magnificent Stocks That Could Double or More by 2030
|
|
Apr 12
|
Shed the Fat, Gain the Profits: 3 Weight-Loss Stocks to Own Until 2027
|
|
Apr 10
|
Viking Therapeutics, Inc. (VKTX) Dips More Than Broader Market: What You Should Know
|
|
Apr 10
|
What Makes Viking Therapeutics (VKTX) an Attractive Potential Opportunity?
|
|
Apr 9
|
Better Buy: CRISPR Therapeutics Vs. Viking Therapeutics
|
|
Apr 9
|
Forget Viking Therapeutics. Here's 1 Weight-Loss Stock to Keep Your Eyes on Instead.
|
|
Apr 8
|
Viking Therapeutics Is Great. Here's Why You Shouldn't Buy It.
|
|
Apr 7
|
10 Best Weight Loss Drug Stocks to Buy Now
|
|
Apr 6
|
Is it Too Late to Buy Viking Therapeutics Stock?
|